Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy ™ Series - Los Angeles, CA held virtually on May 5, 2021 are available here. Program Organizers Edward B. Garon, MD – University of California Los Angeles Blanca A. Ledezma, NP – Ronald Reagan...
22 attachments
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy ™ Series - Detroit, MI held virtually on May 1, 2021 are available here. Program Organizer Shirish Gadgeel, MD – Henry Ford Cancer Institute Program Summary Specifically designed by the...
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy ™ Series - Charlottesville, NC held virtually on April 27, 2021 are available here. Program Organizers Elizabeth M. Gaughan, MD – University of Virginia Cancer Center Ryan D. Gentzler, MD – ...
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy ™ Series - New Brunswick, NJ held virtually on April 29, 2021 are available here. Program Organizers Eric Singer, MD, MA, MS, FACS – Rutgers Cancer Institute of New Jersey Kristen R. Spencer, DO,...
20 attachments
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy ™ Series - Portland, OR held virtually on April 8, 2021 are available here. Program Organizers Rachel Sanborn, MD – Earle A. Chiles Research Institute Sasha Stanton, MD, PhD – Providence Cancer...
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy ™ Series - Memphis, TN held virtually on March 20, 2021 are available here. Program Organizers Axel Grothey, MD – West Cancer Center & Research Institute Lee S. Schwartzberg, MD, FACP – West...
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy™ Series - Atlanta, GA held virtually on January 23, 2021 are available here. Program Organizers Caroline Claar, NP – Winship Cancer Institute of Emory University David H. Lawson, MD – Winship...
The recent development and clinical implementation of novel immunotherapies for the treatment of Hodgkin and non-Hodgkin lymphoma have improved patient outcomes across subgroups. The rapid introduction of immunotherapeutic agents into the clinic, however, has presented significant questions...
Immune effector cell (IEC) therapies offer durable and sustained remissions in significant numbers of patients with hematological cancers. While these unique immunotherapies have improved outcomes for pediatric and adult patients in a number of disease states, as ‘living drugs,’ their toxicity...
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy™ Series - Tucson, AZ held virtually on October 31, 2020 are available here. Program Organizers Emmanuel Katsanis, MD – University of Arizona Ali McBride, PharmD, MS, BCPS, BCOP, FAzPA – University...
18 attachments
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us